Manifold Bio

Senior Security Engineer

Boston, Massachusetts, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Health Research, Healthcare TechnologyIndustries

Requirements

The Senior Security Engineer should possess a strong understanding of security principles, network architecture, and operating systems, with experience in vulnerability scanning, penetration testing, and bug bounties. They must be able to analyze the potential impact of vulnerabilities, assess the likelihood of exploitation, and prioritize vulnerabilities for remediation. Additionally, the candidate should have experience managing the vulnerability lifecycle, driving automation initiatives, and ensuring alignment with industry standards.

Responsibilities

This role involves proactively identifying, assessing, and mitigating security risks within the organization’s systems and networks through techniques such as vulnerability scanning, penetration testing, and bug bounties. The Security Engineer will work with engineering, IT, and other teams to implement patches and mitigation strategies, validate remediation efforts, and continuously monitor systems for new vulnerabilities. Furthermore, they will drive automation of vulnerability scanning and assessment processes, integrate security into the software development lifecycle, and collaborate with other teams to enhance the organization’s overall security posture while maintaining security controls and compliance requirements for handling sensitive data.

Skills

Vulnerability Management
Security Risk Assessment
Security Mitigation
Cybersecurity
Risk Management
Security Tools

Manifold Bio

Designs precision biologics using in vivo methods

About Manifold Bio

Manifold Bio specializes in creating precision biologics for the pharmaceutical industry, focusing on drug design and development. Their main product is an in vivo drug design platform, which allows for testing drugs within living organisms rather than in laboratory settings. This platform utilizes mCodes™ technology, a unique protein barcoding system that enables the simultaneous study of multiple proteins in one experiment, making it particularly effective for complex biologics. Unlike other companies, Manifold Bio's approach to drug design is distinct because it integrates in vivo testing with advanced protein multiplexing capabilities. The company's goal is to expand their platform and collaborate with other pharmaceutical companies to develop new therapeutics.

Boston, MassachusettsHeadquarters
2020Year Founded
$58.8MTotal Funding
SERIES_ACompany Stage
Biotechnology, HealthcareIndustries
11-50Employees

Risks

Increased competition from companies like Insamo and Infinimmune.
Rapid AI and ML advancements may outpace Manifold Bio's current technology.
Regulatory challenges in in vivo testing could delay product development timelines.

Differentiation

Manifold Bio uses proprietary mCodes™ technology for protein multiplexing in drug design.
Their in vivo drug design platform is the first of its kind globally.
The company specializes in precision biologics, focusing on complex biologics development.

Upsides

Raised $40M in Series A funding, indicating strong market interest.
Their platform could revolutionize in vivo testing by testing multiple molecules simultaneously.
Strategic partnerships with multiple investors enhance growth and development opportunities.

Land your dream remote job 3x faster with AI